期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

经导管去肾交感神经术——当前各种技术的优劣比较 被引量：2

Catheter-based Renal Denervation——Comparison of Current Techniques
下载PDF
导出
摘要 作为一种非药物治疗顽固性高血压新技术,经导管去肾交感神经术(renal denervation,RDN)初步已显示出其安全性和有效性。近年来不同治疗方式的RDN专用导管不断发展,基于此现对当前主要的几种经导管RDN技术进行综述。 As a novel non-pharmaceutical method for the treatment of resistant hypertension, transcatheter renal denervation （RDN） has been shown its efficacy and safety in controlling the blood pressure. Numerous new catheter systems based on the different treatment mo- dalities for RDN are under development. We reviewed some major current catheter-based RDN techniques in this article.
作者 卢成志 张瑾
机构地区 天津市第一中心医院心血管病中心
出处 《心血管病学进展》 CAS 2013年第6期722-725,共4页 Advances in Cardiovascular Diseases
关键词 去肾交感神经术 难治性高血压 renal denervation resistant hypertension
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献18

  • 1Sarafidis PA,Bakris GL.Resistant hypertension:an overview of evaluation and treatment[J].J Am Coll Cardiol,2008,52(22):1749-1757.
  • 2孙宁玲,霍勇,王继光,李南方,陶军,李勇,严晓伟,蒋雄京,李学旺.难治性高血压诊断治疗中国专家共识[J].中华高血压杂志,2013,21(4):321-326. 被引量：152
  • 3Salles GF,Cardoso CR,Muxfeldt ES.Prognostic influence of office and ambulatory blood pressures in resistant hypertension[J].Arch Intern Med,2008,168(21):2340-2346.
  • 4Mahfoud F,Luscher TF,Andersson B,et al.Expert consensus document from the European Society of Cardiology on catheter-based renal denervation[J].Eur Heart J,2013,34(28):2149-2157.
  • 5卢成志,刘佳,夏大胜,赵向东,陈欣,于翔,徐建强,张靖,潘丽,刘少颖,王丽.经皮肾动脉射频消融术对犬高血压影响机制的探讨[J].中华心血管病杂志,2012,40(1):14-17. 被引量：17
  • 6Symplicity HTN-1 Investigators.Catheter-based renal sympathetic denervation for resistant hypertension:durability of blood pressure reduction out to 24 months[J].Hypertension,2011,57(5):911-917.
  • 7Esler MD,Krum H,Sobotka PA,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial[J].Lancet,2010,376(9756):1903-1909.
  • 8Esler MD,Krum H,Schlaich M,et al.Renal sympathetic denervation for treatment of drug-resistant hypertension:one-year results from the symplicity HTN-2 randomized,controlled trial[J].Circulation,2012,126(25):2976-2982.
  • 9Kandzari DE,Bhatt DL,Sobotka PA,et al.Catheter-based renal denervation for resistant hypertension:rationale and design of the Symplicity HTN-3 trial[J].Clin Cardiol,2012,35(9):528-535.
  • 10蒋雄京,梁拓,董徽,彭猛,马文君,关婷,张慧敏,卞谨,徐波,高润霖.经导管射频消融肾交感神经治疗难治性高血压的近期疗效和安全性[J].中华医学杂志,2012,92(46):3265-3268. 被引量：16

二级参考文献56

  • 1Lloyd-Jones D, Adams R J, Brown TM, et al . Executive summary : heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation, 2010,121 : e259.
  • 2Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension : analysis of worldwide data. Lancet, 2005,65 : 217- 223.
  • 3Jordan J. Sympathetic genes, baroreflexes, and hypertension. Clin Auton Res ,2004,14:369-375.
  • 4Grisk O, Rettig R. Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res, 2004,61:238-246.
  • 5Grassi G, Arenare F, Pieruzzi F, et al. Sympathetic activation in cardiovascular and renal disease. J Nephrol, 2009,22 : 190-195.
  • 6Smith PA, Graham LN, Mackintosh AF, et al. Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens, 2004,17:217-222.
  • 7Grimson KS. Total thoracic andpartial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg ,19gl ,114:753-775.
  • 8Knepper PA, Neudorff LG, Et A. Hypertension: surgical treatment by transthoracic thoracolumbar sympathectomy. Mo Med, 1949,46 : 855-860.
  • 9Li M, Galligan J, Wang D, et al. The effects of celiac ganglionectomy on sympathetic innervation to the splanchnic organs in the rat. Auton Neurosci, 2010,154:66-73.
  • 10King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension, 2007,50:547-556.

共引文献179

同被引文献38

  • 1匡燕,江凤林.阻断肾交感神经活性治疗慢性肾脏疾病新进展[J].医学信息（医学与计算机应用）,2014,0(6):539-540. 被引量：1
  • 2de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring[ J]. Hypertension, 2011, 57 (5) : 898 -902.
  • 3Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008 [ J ]. Hypertension, 2011, 57 ( 6 ) : 1076 - 1080.
  • 4Cahoun DA, Jones D, Testor S, et al. Resistant hypertension : diag- nosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [ J]. Circulation, 2008, 117(25) : 510 -526.
  • 5Moser M, Setaro JF. Resistant or difficult-to-control hypertension [J]. N EnglJMed, 2006, 355(4): 385 -392.
  • 6Sarafidis PA, Bakris GL. Stant hypertension : an overview of evalua- tion and treatment[ J ]. J Am Coil Cardiol, 2008, 52 (22) : 1749 - 1757.
  • 7Krum H, Sehlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a muhicentre safety and proof-of-principle cohort study[ J]. Lancet, 2009, 373 (9671) : 1275 -1281.
  • 8Sobotka PA, Mahfoud F, Schlaich MP, et al. Sympatho-renal axis in chronic disease [ J ]. Clin Res Cardiol, 2011, 100 (12) : 1049 - 1057.
  • 9Shen M, Zipes DP. Role of the autonomic nervous system in modu- lating cardiac arrhythmias[ J ]. Circ Res, 2014, 114 (6) : 1004 -1021.
  • 10Ewen S, Ukena C, 1,iuz D, et al. The sympathetic nervous system in chronic kidney disease[J]. Curt Hypertens Rep, 2013, 15(4): 370 - 376.

引证文献2

二级引证文献2

心血管病学进展
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部